San Francisco, California, December 28, 2017 – The global diagnostic imaging market is anticipated to gain momentum on the back of technological developments witnessed in the diagnostic imaging techniques domain. TMR Research prognosticates the market to also achieve success while riding on increasing geriatric population, and the mounting prevalence of various diseases on the global platform. Titled “Diagnostic Imaging Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” a report by the research company foresees market expansion to obtain support from several private organizations and governments investing heavily in the development of new products.
Vendors could attain strong growth prospects due to the rise of X-ray-based examinations, a popular method of diagnostic imaging across the world. Risks such as cancer associated with the exposure to X-radiation are projected to cut short the growth of the world diagnostic imaging market. However, the negative impact on the market could be overcome while cashing in on crucial growth opportunities birthing from the advent of new products. The development of the market could be relied upon because of the increasing awareness about the early diagnosis of clinical issues, increasing count of restorative imaging systems, and quickly maturing populace. Moreover, the growing incidence of incessant diseases and innovation in the area of diagnostic imaging gadgets could create scores of market opportunities.
On the regional front, North America could secure a dominating status in the international diagnostic imaging market in the presence of other vital regions such as Rest of the World, Europe, and Asia Pacific. The growth in North America could be ascribed to the disturbing rise of cancer and other diseases and medical conditions. With India, Japan, and China securing a larger share in the Asia Pacific market, the region is expected to showcase a tremendous growth in the coming years. The growth in Asia Pacific could be propelled due to the rise of certain factors such as promising government policies, increasing healthcare spending, swelling occurrences of chronic diseases, and growing awareness about the benefits and availability of diagnostic imaging tests.
Market leaders are foreseen to take to the adoption of crucial business tactics including collaborations, partnerships, and mergers and acquisitions to outplay their opponents in the industry. This could be evident with MedyMatch Technology’s announcement of collaboration with IBM Watson Health in Q1 2017. The main objective of this collaboration is to assist physicians in diagnosing intracranial bleeding resulting due to head trauma and stroke while making available cognitive tools for imaging professionals working in critical settings such as hospital emergency rooms. During the same period, another company based in Minneapolis named CorVascular Diagnostics, LLC, which deals with medical technology, publicized its collaboration with intravenous therapy medical devices manufacturer, Novarix, Inc.
The worldwide diagnostic imaging market could testify the presence of GE Healthcare, Siemens Healthcare GmBH, Toshiba Medical Systems Corporation, and other players. Several companies are turning their focus toward the development of novel devices for the purpose of allowing faster and more precise diagnosis. From 2017, 128-sliced CT scans started to be offered by Sequoia Hospital for the accurate diagnosis of medical conditions. Healthcare professionals could assure patients of a minimal exposure to radiation with the help of this new 3D technology. Simultaneously, the technology could offer faster results and high imaging quality. The launch of India’s Mahajan Imaging diagnostic center follows suit.
Get Sample Copy of this Report